UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000023689 |
|---|---|
| Receipt number | R000027283 |
| Scientific Title | A pharmacokinetic study of active ingredient in hair restorer. |
| Date of disclosure of the study information | 2016/08/20 |
| Last modified on | 2018/05/24 15:06:06 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A pharmacokinetic study of active ingredient in hair restorer.
Acronym
A pharmacokinetic study of active ingredient in hair restorer.
Scientific Title
A pharmacokinetic study of active ingredient in hair restorer.
Scientific Title:Acronym
A pharmacokinetic study of active ingredient in hair restorer.
Region
| Japan |
Condition
Condition
alopecia prematura
Classification by specialty
| Dermatology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To confirm the active ingredient kinetics in blood and urine after administration of hair restorer.
Basic objectives2
Pharmacokinetics
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Pharmacokinetic parameter of active ingredient in hair restorer calculated from the concentration of blood concentration before administration and 1,2,4,6,8,12,24,48hrs after, and urinary concentration before administration and 2,4,6,8,12,24hrs after.
Key secondary outcomes
1)Photographs of occipital and parietal region scalp.
2)Results of blood chemical analysis and skin surface topography before administration.
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Medicine |
Interventions/Control_1
Administration of commercial hair restorer on scalp twice at an interval of 2 weeks.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 60 | years-old | > |
Gender
Male
Key inclusion criteria
1) Mail patients with alopecia premature (typeVI or early- or mid-stage of typeII and typeIV in Ogata's classification)
2) Patients with 60-75kg body weight.
3) Non-smoker
4) Patients with negative in viral test,
5) Patients without problem in health especially in metabolic function.
Key exclusion criteria
1) Patients taking or using medicine which can have influence on the result.
2) Patients having daily health food which can have influence on the result.
3) Patients who is capable to have allergic responses to constituent parts of test articles.
4) Patients participating in other clinical tests.
5) Patients with any histories of hepatic disorder,nephropathy,heart disease,dysuria.
6) Patients with alopecia other than alopecia premature or unexplained alopecia.
7) Patients with rapid hair loss or patchy alopecia
8) Patients with wound or eczema or inflammation on scalp
9) Patients with allergic responses to any drug or cosmetic.
10) Patients treated for hypotension or hypertension.
11) Patients with systolic pressure under 100mmHg or above 160mmHg.
12) Patients with diastolic pressure above 110mmHg.
13) Patients with swelling.
14) Patients with thyroid dysfunction.
15) Patients with arrhythmia and severe anemia.
16) Patients using anticoagulant.
17) Patients with subjective symptoms of anemia.
18) Patients whose blood was collected over 400mL during 3 months or over 200mL during 2 months.
19) Patients treated hair addition or hair transplantation.
20) Patients haven one's hair permed in 1 month.
21) Patients with histories of positives in virus test.
22) Patients met any of following criterias.
-Total cholesterol:280mg/dL or more
-Triglyceride:400 mg/dL or more
-FBG:130 mg/dL or more
-Uric acid:9.0 mg/dL or more
-Creatinine:1.5 mg/dL or more
23) Patients with 2.5 times more than standard value of either g-GT,AST,ALT,direct bilirubin or total bilirubin.
24) Patients deemed inappropriate to participate in this study by the principal investigator or sub-investigators.
Target sample size
14
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Takashi Koikeda |
Organization
Shiba Palace Clinic
Division name
Chief of Clinic
Zip code
Address
Daiwa A Hamamatsu-cho Bldg. 6F, 1-9-10, Hamamatsu-cho, Minato-ku, Tokyo, 105-0013, JAPAN
TEL
03-5408-1599
jimukyoku@mail.souken-r.com
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Reiko Maruya |
Organization
SOUKEN CO.,LTD
Division name
Secretariat
Zip code
Address
Hamamatsu-cho, Minato-ku, Tokyo, 105-0013, JAPAN
TEL
03-5733-1555
Homepage URL
r_maruya@mail.souken-r.com
Sponsor or person
Institute
SOUKEN CO.,LTD
Institute
Department
Personal name
Funding Source
Organization
Kao Corporation
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
株式会社SOUKEN（東京都）
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 08 | Month | 20 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2016 | Year | 06 | Month | 23 | Day |
Date of IRB
Anticipated trial start date
| 2016 | Year | 08 | Month | 20 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
| 2018 | Year | 05 | Month | 24 | Day |
Date analysis concluded
| 2018 | Year | 05 | Month | 24 | Day |
Other
Other related information
Management information
Registered date
| 2016 | Year | 08 | Month | 19 | Day |
Last modified on
| 2018 | Year | 05 | Month | 24 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027283
